期刊文献+

成纤维激活蛋白的研究现状与展望

Current status and perspective in research of fibroblast activation protein
原文传递
导出
摘要 目的总结成纤维激活蛋白(fibroblast activation protein,FAP)的功能、作用机制以及其在靶向治疗方面的应用。方法复习近年来国内外有关FAP的相关研究文献并进行综述。结果 FAP与人二肽基肽酶Ⅳ具有重要的联系,具有丝氨酸蛋白酶活性,是肿瘤微环境中重要的免疫抑制成分。FAP参与肿瘤性和非肿瘤性疾病的病理过程。在靶向治疗中,针对FAP的酶活性抑制物、抗体、疫苗及前体药物被广泛研究。结论 FAP功能多样,参与多种疾病的病理过程,同时对肿瘤靶向治疗的研究具有重要意义。 Objective To summarize functions and mechanisms of fibroblast activation protein (FAP) and its application in targeted therapy. Method Literatures about FAP in recent years were collected to make a review. Results There is an important relationship between the FAP and the dipeptidyl peptidase-IV. FAP has a serine protease activity and is an important immunosuppressive component in the tumor microenvironment. FAP participate in the pathological process of the neoplastic and the non-neoplastic diseases. In the targeted therapy, the enzyme inhibitors, antibodies, vaccines, and prodrugs of FAP had been extensively studied. Condusion FAP have various functions and participates in pathological process of many diseases, and it is of great significance to research of tumor targeted therapy.
出处 《中国普外基础与临床杂志》 CAS 2017年第10期1284-1288,共5页 Chinese Journal of Bases and Clinics In General Surgery
关键词 成纤维激活蛋白 肿瘤 靶向治疗 fibroblast activation protein tumor targeted therapy
  • 相关文献

参考文献2

二级参考文献17

  • 1Trouet A,Passioukov A,Van derpoorten K,et al.Extracellularlytumor-activated prodrugs for the selective chemotherapy of cancer:application to doxorubicin and preliminary in vitro and in vivostudies.Cancer Res,2001,61(7):2843-2846.
  • 2Cheng J D,Dunbrack R L Jr,Valianou M,et al.Promotion oftumor growth by murine fibroblast activation protein,a serineprotease,in an animal model.Cancer Res,2002,62(16):4767-4772.
  • 3Rooseboom M,Commandeur J N,Vermeulen N P.Enzyme-catalyzed activation of anticancer prodrugs.Pharmacol Rev,2004,56(1):53-102.
  • 4Eimon P M,Rubinstein A L.The use of in vivo zebrafish assaysin drug toxicity screening.Expert Opin Drug Metab Toxicol,2009,5(4):393-401.
  • 5Sukardi H,Chng H T,Chan E C,et al.Zebrafish for drugtoxicity screening:bridging the in vitro cell-based models and invivo mammalian models.Expert Opin Drug Metab Toxicol,2011,7(5):579-589.
  • 6Westerfield M.The Zebrafish Book:a guide for the laboratory useof zebrafish(Danio rerio).5th edition.Eugene:University ofOregon Press,2007.http://zfin.org/zf_info/zfbook/zfbk.html.
  • 7Baurain R,Masquelier M,Deprez-De Campeneere D,et al.Amino acid and dipeptide derivatives of daunorubicin.2.Cellularpharmacology and antitumor activity on L1210 leukemic cells invitro and in vivo.J Med Chem,1980,23(11):1171-1174.
  • 8Ravel D,Dubois V,Quinonero J,et al.Preclinical toxicity,toxicokinetics,and antitumoral efficacy studies of DTS-201,atumor-selective peptidic prodrug of doxorubicin.Clin Cancer Res,2008,14(4):1258-1265.
  • 9Khong H T,Restifo N P.Natural selection of tumor variants inthe generation of"tumor escape"phenotypes.Nat Immunol,2002,3(11):999-1005.
  • 10Fassnacht M,Lee J,Milazzo C,et al.Induction of CD4(+)and CD8(+)T-cell responses to the human stromal antigen,fibroblast activation protein:implication for cancerimmunotherapy.Clin Cancer Res,2005,11(15):5566-5571.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部